New antimicrobials : for the present and the future / I.W. Fong.
Fong, I. W. (Ignatius W.), author.
2023
RM267
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title New antimicrobials : for the present and the future / I.W. Fong.
Author Fong, I. W. (Ignatius W.), author.
ISBN 9783031260780 (electronic bk.)
3031260783 (electronic bk.)
3031260775
9783031260773
DOI https://doi.org/10.1007/978-3-031-26078-0
Published Cham, Switzerland : Springer, 2023.
Language English
Description 1 online resource (192 pages).
Other Standard Identifiers 10.1007/978-3-031-26078-0 doi
Call Number RM267
Dewey Decimal Classification 615.7/92
Summary This is a timely and essential companion to the recently published Antimicrobial Resistance in the 21st Century, Second Edition. Antimicrobial resistance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO's top priorities, but in 2017, it conceded that the current drug development pipeline was insufficient to mitigate the threat. This book discusses recent progress and bolster new agent discovery and development, by providing researchers and students who will soon enter the field with a thorough guide to the advancements made in the last decade. Coverage includes new systemic antimicrobials approved since 2010, with detailed analysis of antibiotics, antivirals, antifungals, and antiparasitics, as well as agents in development for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparison. This volume is designed for researchers and students of infectious disease and medical microbiology, as well as clinicians in need of a comprehensive guide to newly developed agents.
Bibliography, etc. Note Includes bibliographical references and index.
Access Note Access limited to authorized users.
Source of Description Description based on print version record.
Series Emerging infectious diseases of the 21st century.
Available in Other Form NEW ANTIMICROBIALS.
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
1. Antimicrobial Resistance: A crisis in the making
2: New Cephalosporins: 5th and 6th generations
3: New -lactam
lactamase inhibitor combinations
4: New Glycopeptides: Televancin, dalbavancin and oritavancin
5: A new fluoroquinoloneDelafloxacin
6: New Oxazolininone
-Tedizolid
7: New Tetracyclines: Eravacycline and Omadacycline
8: Pleuromutilin: A new class of antibiotic: Lefamulin
9: New anti-tuberculous drugs: Bedaquiline, Delamanid and Pretomanid
10: New systemic antifungal: Isavuconazole
11: Newly approved anti-parasitic drugs for malaria, fascioliasis, onchocerciasis, Chagas disease and African trypanosomiasis
12:New antiretroviral agents for HIV infection
13: New Antiviral agents for cytomegalovirus diseases
14: New antiviral agent for influenza: Baloxavir
15: Direct antiviral agents for hepatitis C
16: Antiviral drugs for SARS-CoV-2 and COVID-19
17: New promising antimicrobials in development and novel approaches for treatment of infections.

Browse Subjects

Show more subjects...

Statistics

from
to
Export